Thymalin
Research PhaseThymalin (Thymic Polypeptide Complex)
- Category
- Immune & Inflammatory
- Aliases
- Thymaline, TP-1
- Administration
- Intramuscular injection
Timing
A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.
- 1
1–2 Weeks
Since the typical studied course is only 5-10 days, most reported changes in immune markers occur within this initial window.
- 2
3–4 Weeks
Effects on immune markers are generally assessed shortly after a short treatment course ends, around this timeframe.
- 3
5–7 Weeks
Some studies describe repeat courses spaced out to this point, rather than continuous daily use.
- 4
8–10 Weeks
Available research does not describe continuous use at this duration; short repeat courses are the studied pattern.
- 5
11–15 Weeks
Available research does not describe continuous use at this duration.
- 6
16–20 Weeks
Available research does not describe continuous use at this duration.
- 7
21–24 Weeks
Repeat short courses every few months is the pattern described in available Russian clinical research, rather than continuous dosing through this duration.
⚠️ Research context only. This is not medical advice and results are not guaranteed.